Dare Bioscience, Inc. — Director's Dealing 2014

Apr 10, 2014

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Cerulean Pharma Inc. (CERU)
CIK: 0001401914
Period of Report: 2014-04-10

Reporting Person: TEPPER ROBERT I (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	18954	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$3.34	2021-01-27	Common Stock (3447)		Direct

Footnotes

F1: Reflects a 1-for-14.5074 reverse stock split effected on March 31, 2014.

F2: This option was granted on January 28, 2011. This option vested as to 6.25% of the underlying shares on March 18, 2011 and vests as to an additional 6.25% of the shares quarterly thereafter through and including December 14, 2014. The Reporting Person exercised the option in part on February 14, 2013.